Anbio Biotechnology Class A's total assets for Q4 2024 were $18.92M, a decrease of -0.11% from the previous quarter. NNNN total liabilities were $1.73M for the fiscal quarter, a 227.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.